Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 2Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Leukemia, Myeloid, Acute 35Myelodysplastic Syndromes 27Lymphoma, Non-Hodgkin 25Lymphoma 20Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20Leukemia 20Hodgkin Disease 14Central Nervous System Neoplasms 13Breast Neoplasms 13Hematologic Neoplasms 12Leukemia, Lymphocytic, Chronic, B-Cell 11Neuroblastoma 9Burkitt Lymphoma 9Multiple Myeloma 8Lymphoma, Large B-Cell, Diffuse 8Myeloproliferative Disorders 7Leukemia, Myeloid, Accelerated Phase 7Leukemia, Biphenotypic, Acute 7Lymphoma, Follicular 6Graft vs Host Disease 6Dendritic Cell Sarcoma, Interdigitating 6Congenital Abnormalities 6Brain Neoplasms 6Blast Crisis 6Anemia, Refractory, with Excess of Blasts 6Testicular Neoplasms 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, B-Cell, Marginal Zone 5

Interventions

Bevacizumab 10Magnetic Resonance Spectroscopy 9Temozolomide 8Cyclophosphamide 8Etoposide 7X-Rays 6Phantoms, Imaging 6Specimen Handling 5Nuclear Medicine Department, Hospital 5Cisplatin 5Radiotherapy 4Irinotecan 4Filgrastim 4Carboplatin 4Biopsy 4Erlotinib Hydrochloride 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2sargramostim 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2etoposide phosphate 2erdafitinib 2ensartinib 2Vincristine 2Vemurafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Ependymoma × Thiotepa × Clear all
NCT00528437 2021-07-08

Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

NYU Langone Health

Phase 2 Completed
46 enrolled 5 charts
CNS

Brain Neoplasms, Ependymoma, Glioma, Recurrence

NCT00008008 2013-02-04

Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma

National Cancer Institute (NCI)

Phase 2 Completed
40 enrolled
CNSSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡